Lithium and Your Kidneys: What the Research Really Shows

Peter ForsterBipolar Treatment, Physical Conditions and Health

Updated 11-17-2026

Lithium is one of the most effective treatments we have for bipolar disorder. It prevents manic and depressive episodes and is the only mood stabiliser with good evidence for reducing suicide nice.org. A common worry is what it does to the kidneys over many years. This post summarises what the large long-term studies show, in plain terms, and what you and your doctor can do to keep your kidneys healthy.

The short version: lithium causes a small, slow extra loss of kidney function in some people over many years. Serious kidney failure is uncommon. Most of the risk can be managed with regular blood tests, sensible lithium levels, and good care of your general health.

A quick guide to kidney tests

Tests of kidney filtering (for CKD)

  • Creatinine is a waste product measured in a routine blood test. When the kidneys filter less well, creatinine rises.
  • eGFR (estimated glomerular filtration rate) is calculated from creatinine, age and sex. It is roughly the percentage of normal kidney filtering. An eGFR of 90 or more is normal; 60–89 is mildly reduced and very common with age.
  • Chronic kidney disease (CKD) stage 3 means an eGFR below 60 for at least three months. Most people with stage 3 CKD have no symptoms and never need dialysis.
  • End-stage kidney disease means the kidneys work so poorly that dialysis or a transplant is needed. This is the outcome people usually fear, and it is rare on lithium.

Everyone loses a little kidney function with age. In a Swedish study, both people with bipolar disorder and the general population lost about half a point of eGFR per year from ageing alone kitsap.

Tests of the kidneys’ ability to save water (for diabetes insipidus)

These are used if you are thirsty or passing a lot of urine. Diabetes insipidus is explained further below.

  • Urine concentration (specific gravity or osmolality) shows how concentrated your urine is. Specific gravity is often part of a routine urine dipstick test; a persistently low value (below about 1.010) is a reason to measure urine osmolality, which is more precise nice.org.
  • Blood sodium and blood osmolality show whether the body is short of water. Very dilute urine at a time when the blood is concentrated points to diabetes insipidus nice.org.
  • 24-hour urine collection measures how much urine you pass in a day. More than about 3 litres confirms that there is genuinely too much urine (polyuria) nice.org+1.
  • Copeptin is a blood test that reflects vasopressin, the hormone that tells the kidneys to save water. In people who are already known to pass a lot of urine, a high level (21.4 pmol/L or more) strongly suggests diabetes insipidus, without the need for longer testing nice.org. It is mainly used in specialist settings and is not available everywhere.
  • Water deprivation test. In this traditional test, you go without fluids under supervision and are then given a dose of synthetic vasopressin (desmopressin) to see whether the kidneys respond. It is done in hospital and is rarely needed now nice.org+1.

Comparing like with like

People with bipolar disorder have more kidney disease than the general population whether or not they take lithium jamanetwork+1. So the fair question for someone who needs treatment is not “lithium or nothing”, but “how does lithium compare with treating bipolar disorder some other way?” Wherever possible, the figures below compare people with bipolar disorder (or other mood disorders) who take lithium with those who do not.

What the main studies found

Denmark (Kessing et al., 2015)

This study followed everyone in Denmark diagnosed with bipolar disorder over up to 17 years, using hospital records jamanetwork.

  • Lithium use was linked to more diagnoses of CKD, and the risk rose with longer use.
  • Lithium was not linked to more end-stage kidney disease.
  • Among people with bipolar disorder, other mood stabilisers (anticonvulsants such as valproate) were linked to a similar rise in CKD.
  • Bipolar disorder itself was linked to more kidney disease, regardless of treatment.
  • In absolute terms, over the follow-up period about 2.6% of people with bipolar disorder were diagnosed with definite CKD and 0.6% with end-stage disease.

The lead author, Dr. Lars Vedel Kessing, told Reuters Health that the most important finding was that lithium “can be used in a safe way, not resulting in end-stage chronic kidney disease”. He suggested the extra kidney disease seen in bipolar disorder is mostly due to heart and blood vessel risk factors, which deserve more attention.

Bar charts of chronic and end-stage kidney disease risk by number of lithium prescriptions in Danish patients with bipolar disorder

Figure: Risk of kidney disease in Danish patients with bipolar disorder, by how long they had taken lithium, compared with patients with bipolar disorder who were not taking lithium jamanetwork. A hazard ratio of 1 means the same risk; 2 means twice the risk. The vertical lines show the range of uncertainty. Diagnoses of chronic kidney disease rose steadily with longer use, to about 2.5 times the risk after 60 or more prescriptions. End-stage kidney disease was rare (62 cases among 10,591 patients) and did not increase with longer use. The higher values after only a few prescriptions are based on very small numbers.

The study had no blood test results, so it could not look at lithium levels or kidney function directly.

Iceland (Gislason et al., 2024)

This study used actual blood test results for everyone in Iceland on lithium for a mood disorder, compared with outpatients with mood disorders who had never taken lithium cprd.

  • Over about a decade, stage 3 CKD developed in about 10 in 100 people on lithium, compared with about 3 in 100 people not on lithium.
  • The risk depended strongly on the lithium level. At average levels of 0.30–0.59 mmol/L, the risk was barely higher than without lithium. At 0.60–0.79 it was roughly three times higher, and at 0.80–0.99 roughly four times higher.
  • Older age, lower kidney function at the start, diabetes and previous episodes of sudden kidney injury also increased the risk.

This study measured mild-to-moderate kidney changes (stage 3), not kidney failure.

Other long-term studies

StudyWho was studiedWhat it found
UK, 2014 journals.plos6,360 people with bipolar disorderKidney problems were more common in those who had taken lithium. In people under 50, the extra risk of kidney failure was very small (about 1 or 2 in 1,000). In people over 50 it was about 1 extra case in 44
UK, 2016 thelancetPeople with bipolar disorder taking lithium, valproate, olanzapine or quetiapineStage 3 CKD was more common on lithium, but severe kidney failure was equally rare on all four drugs
Sweden, 2022 kitsap785 people with bipolar disorder compared with the general populationLithium added about half a point of eGFR loss for each year of treatment. The difference became clear only after more than 10 years, and many people showed no extra loss at all
Sweden, 2023 pmc.ncbi.nlm.nihNew users of lithium compared with new users of valproateOverall, kidney disease did not progress faster on lithium. Risk rose with many years of use and with levels above 1.0 mmol/L
Hong Kong, 2025 bmcnephrol.biomedcentral7,029 people with bipolar disorderLithium was linked to about a one-third higher risk of stage 3 CKD than valproate or antipsychotics, but not to more kidney failure. Risk rose mainly when average levels were above about 0.6 and with each level above 1.0
Sweden, 2025 journals.sagepub168 long-term users who stopped lithiumThe slow decline in kidney function largely stopped after lithium was discontinued
Combined analysis, 2026 pmc.ncbi.nlm.nih16 studieseGFR was lower on average in people taking lithium, but the studies varied a lot. Overall, new or worsening CKD was not clearly more common

Putting it in perspective

  • The extra risk is mainly mild to moderate CKD, not kidney failure. Across studies, people on lithium are more likely to reach an eGFR below 60, but dialysis or transplant remains rare.
  • It builds slowly. For most people the extra loss is small in the first 10 years. It matters most after many years of treatment and for people who start lithium later in life or already have reduced kidney function pmc.ncbi.nlm.nih.
  • Levels matter. Keeping levels in the lower part of the effective range and, above all, avoiding levels above 1.0 mmol/L reduces the risk cprd+2. Most people do well at 0.6–0.8 mmol/L; your doctor may suggest a slightly lower target as you get older or if kidney function falls.
  • It varies a lot between people. Many long-term users show no extra decline; a minority decline faster. Regular blood tests identify who is who.
  • Bipolar disorder that is not well controlled carries serious risks of its own. For most people, the benefits of lithium outweigh a small, monitored kidney risk.

Thirst and passing a lot of urine: lithium-induced diabetes insipidus

Many people on lithium notice they are thirstier and pass more urine than before, including at night. This is the most common kidney side effect of lithium, and it is quite separate from the slow change in filtering (eGFR) discussed above nice.org. Doctors have long called it nephrogenic diabetes insipidus. It is now often called arginine vasopressin resistance (AVP-R). Despite the name, it has nothing to do with sugar diabetes.

What is known

  • What happens. Normally, a hormone called vasopressin tells the kidneys to save water and concentrate the urine. Lithium builds up in the cells that respond to this hormone and blunts their response, so the kidneys let more water through nice.org+1.
  • How common it is. Some increase in urine volume affects between about 20 and 87 in 100 people on lithium, depending on how it is measured. The full condition, usually defined as more than about 3 litres of urine a day, affects about 3 to 17 in 100 nice.org.
  • When it starts. It can appear within 2–4 months of starting lithium, much earlier than any change in eGFR nice.org. Waking at night to pass urine is often the first sign nice.org.
  • How serious it is. For most people it is a nuisance rather than a danger, as long as they can drink enough nice.org. The main risk is dehydration and a high blood sodium level if fluid intake cannot keep up, for example during vomiting, a heatwave, surgery, or a hospital stay where drinking is restricted nice.org+1. Dehydration also raises lithium levels.
  • Whether it goes away. If it is recent, it often improves when the dose is lowered or lithium is stopped. After many years it often persists even if lithium is stopped nice.org.

What can be done

  1. Tell your doctor. Thirst, passing a lot of urine and getting up at night are worth mentioning at every visit nice.org. Not all thirst on lithium is diabetes insipidus: dry mouth from other medicines, high blood sugar or high calcium can look similar, so it is worth checking nice.org.
  2. Tests. A urine sample to see how concentrated it is (osmolality), blood sodium, and sometimes a 24-hour urine collection nice.org+1. A blood test called copeptin can help in specialist settings but is not yet a routine screening test nice.org.
  3. Adjust the lithium. Using the lowest effective level and taking it once a day may reduce the problem nice.org.
  4. Medication. Amiloride, a mild diuretic, blocks lithium from entering the affected kidney cells. Small studies show it reduces urine volume and improves urine concentration nice.org+1. It is used off-label and needs checks of potassium and kidney function. Thiazide diuretics can also reduce urine volume, but they raise lithium levels, so the lithium dose usually has to be lowered and levels checked closely nice.org+1.
  5. Everyday measures. Keep water within reach, including at night and when travelling. Avoid very salty or high-protein diets, which increase urine volume nice.org. If you go into hospital or are told not to eat or drink before a procedure, tell the staff that you take lithium and pass a lot of urine.

What is not known

  • Does it lead to CKD? Nobody knows for certain whether diabetes insipidus is an early warning sign of later kidney damage, or a separate problem that simply happens in the same people. Lithium affects the same part of the kidney in both conditions, and some experts see them as stages of one process nice.org. One recent kidney specialists’ review describes diabetes insipidus as an independent risk factor for lithium-related kidney damage nice.org. A 2026 expert consensus says it does not, in itself, predict advanced CKD nice.org. Most people with lithium-related thirst and urine changes never develop serious kidney disease.
  • Does amiloride protect the kidneys long term? In rats, amiloride reduced kidney scarring caused by lithium but did not prevent small cysts in the kidney psychiatrist+1. There are no long-term studies in people. A placebo-controlled trial is under way and is also measuring eGFR over a year merckmanuals.
  • Does early detection change the outcome? It is not known whether picking up mild concentrating problems early, for example with copeptin or urine tests, prevents later kidney problems nice.org.
  • How much do lithium levels matter? Some studies link higher levels to worse urine concentrating ability, but others do not nice.org.

Your general health matters as much as lithium

People with bipolar disorder have higher rates of high blood pressure, diabetes, raised cholesterol, smoking and weight gain. These are major causes of kidney disease in their own right, and they are often under-treated in people with bipolar disorder. In one large UK study, people with bipolar disorder and high blood pressure or heart disease were more likely to receive no medication for it, and less likely to receive more intensive treatment, than people without bipolar disorder nice.org. Treating these conditions properly is one of the most effective ways to protect your kidneys, whatever medication you take for your mood.

  • Blood pressure. Have it checked regularly and treated if it is high. Some blood pressure medicines (ACE inhibitors and angiotensin receptor blockers) are particularly good for the kidneys but can raise lithium levels, so your lithium level should be checked after starting one nice.org+1. Water tablets (diuretics) need similar care.
  • Diabetes and weight. Keep blood sugar well controlled. Some mood medications, including lithium and valproate, can cause weight gain and affect blood sugar, so regular checks of weight, glucose and cholesterol are worthwhile cambridge.
  • Smoking. Stopping smoking protects both the heart and the kidneys.
  • Calcium and the parathyroid glands. Lithium can make the parathyroid glands overactive, which raises blood calcium. This affects roughly 5 in 100 long-term users onlinelibrary.wiley. High calcium can cause kidney stones and speed up kidney decline nice.org, so calcium should be checked at least once a year. If it is raised, a parathyroid hormone (PTH) test follows. This is very treatable: surgery to remove the overactive gland or glands cures most people, and many can then continue lithium onlinelibrary.wiley. A tablet called cinacalcet is an alternative for some people nice.org.
  • Thyroid. Lithium often lowers thyroid function. This is easily treated with thyroid hormone tablets and should be checked regularly jamanetwork.
  • Painkillers. Avoid regular anti-inflammatory painkillers such as ibuprofen, naproxen and diclofenac. They raise lithium levels and can harm the kidneys nice.org. Paracetamol is usually a safer choice; ask your doctor or pharmacist.

What happens if kidney function starts to fall

A lower eGFR result is a reason for a careful review, not panic. Kidney changes on lithium usually develop slowly, over years, which leaves time to act.

  1. Confirm it. A single low reading can be caused by dehydration, a recent illness, a heavy meat meal or exercise. The test is repeated, sometimes with a second marker called cystatin C, and a urine test for protein pmc.ncbi.nlm.nih+1.
  2. Look for other causes. High blood pressure, diabetes, high calcium, other medicines and urinary problems can all affect the kidneys, and many of these are treatable nice.org.
  3. Adjust the lithium. Your doctor may lower your target level, switch to once-daily dosing, or check levels more often nice.org+1.
  4. Protect the kidneys generally. Good blood pressure and blood sugar control, avoiding anti-inflammatory painkillers and staying well hydrated all help. A newer group of kidney-protective medicines (SGLT2 inhibitors, such as dapagliflozin and empagliflozin) may slow kidney decline. Evidence in people on lithium is still early, and these medicines can lower lithium levels, so levels need checking nice.org.
  5. See a kidney specialist. A referral is usually made if eGFR falls below about 60, falls quickly, or if there is protein in the urine or high calcium nice.org+1.
  6. Decide together whether to continue lithium. This is a shared decision between you, your psychiatrist and your kidney specialist, weighing your mental health against your kidney health. Many people with mild CKD continue lithium safely with closer monitoring. If kidney function keeps falling, stopping lithium usually halts the decline journals.sagepub. This works best if the decision is made before eGFR falls very low (around 30–40) nice.org, which is why regular monitoring matters.

Never stop lithium suddenly on your own. Stopping abruptly increases the risk of a relapse, particularly mania. If lithium is stopped, it is tapered gradually and replaced with another treatment, with close follow-up nice.org.

What you can do day to day

  • Have your blood tests when they are due: lithium level, kidney function, calcium and thyroid, usually every 3–6 months.
  • Take lithium exactly as prescribed, and ask whether once-daily dosing is suitable for you.
  • Drink enough fluid, especially in hot weather, during exercise and when unwell.
  • If you have vomiting, diarrhoea or a fever and cannot keep fluids down, contact your doctor. You may be advised to pause lithium for a day or two (“sick day rules”).
  • Tell every doctor, dentist and pharmacist that you take lithium before starting any new medicine.
  • Keep up with checks of blood pressure, weight, blood sugar and cholesterol.
  • Report new or increased thirst, or passing a lot of urine, especially at night. If this is a problem for you, keep water handy and tell hospital staff about it.

The bottom line

For people with bipolar disorder who need long-term treatment, lithium remains one of the best options. It carries a small, slowly developing risk to the kidneys, mostly in the form of mild-to-moderate changes rather than kidney failure. The risk is lower with sensible levels, no episodes of toxicity, and good control of blood pressure, diabetes and calcium. With regular monitoring, problems are usually found early, when there is still time to act.

References

  1. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study. JAMA Psychiatry. 2015;72(12):1182–1191. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2467821
  2. Gislason G, Indridason OS, Sigurdsson E, Palsson R. Risk of chronic kidney disease in individuals on lithium therapy in Iceland: a nationwide retrospective cohort study. Lancet Psychiatry. 2024;11(12):1002–1011. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(24)00324-9/abstract
  3. Close H, Reilly J, Mason JM, et al. Renal Failure in Lithium-Treated Bipolar Disorder: A Retrospective Cohort Study. PLoS One. 2014;9(3):e90169. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090169
  4. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386:461–468. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61842-0/fulltext
  5. Hayes JF, et al. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. PLoS Med. 2016;13(8):e1002058. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002058
  6. Fransson F, Werneke U, Harju V, et al. Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts. Lancet Psychiatry. 2022;9:804–814. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00265-6/fulltext
  7. Bosi A, et al. Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden. JAMA Netw Open. 2023;6:e2322056. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807058
  8. Golic M, Aiff H, Attman PO, et al. Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study. Int J Bipolar Disord. 2023;11:39. http://www.link.springer.com/article/10.1186/s40345-023-00319-2
  9. Chan JKN, Solmi M, Correll CU, et al. Lithium for Bipolar Disorder and Risk of Thyroid Dysfunction and Chronic Kidney Disease. JAMA Netw Open. 2025;8(2):e2458608. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830093
  10. Fransson F, et al. Kidney function decline improves after lithium discontinuation. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11846072/
  11. Macaron MM, et al. Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders. Ther Adv Psychopharmacol. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12921164/
  12. Lithium effects on renal functioning: an expert opinion and management algorithm. Int J Bipolar Disord. 2026. https://link.springer.com/article/10.1186/s40345-026-00423-z
  13. Treatment of lithium-induced side-effects: contemporary review. BJPsych Advances. https://www.cambridge.org/core/journals/bjpsych-advances/article/treatment-of-lithiuminduced-sideeffects-contemporary-review/A729612F258839A0FBF721C0EA3D2752
  14. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.
  15. Smith DJ, Martin D, McLean G, et al. Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross-sectional study. BMC Med. 2013;11:263. https://pmc.ncbi.nlm.nih.gov/articles/PMC3880052/
  16. Krishnan N, Perazella MA. Diagnosis and Management of Acute and Chronic Lithium-Associated Nephrotoxicity. J Am Soc Nephrol. 2026;37(8):1789–1801. https://pmc.ncbi.nlm.nih.gov/articles/PMC13441143/
  17. Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. https://www.jacc.org/doi/10.1016/j.jacc.2022.06.017
  18. Lithium-associated hyperparathyroidism: a systematic review of prevalence and surgical outcomes. Langenbecks Arch Surg. 2026. https://link.springer.com/article/10.1007/s00423-026-04200-5
  19. Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (case report and review). https://pmc.ncbi.nlm.nih.gov/articles/PMC8374931/
  20. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf
  21. NICE NG203. Chronic kidney disease: assessment and management. https://www.nice.org.uk/guidance/NG203/chapter/recommendations
  22. Bedford JJ, et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol. 2008;3:1324–1331. https://pmc.ncbi.nlm.nih.gov/articles/PMC2518801/
  23. Amiloride modifies the progression of lithium-induced renal interstitial fibrosis (rat model). Nephrology. https://onlinelibrary.wiley.com/doi/10.1111/nep.12929
  24. Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in a long-term rat model. 2024. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.202400063
  25. AMIND trial: Amiloride for nephrogenic diabetes insipidus in patients with bipolar disorder treated with lithium. ClinicalTrials.gov NCT05044611. https://clinicaltrials.gov/study/NCT05044611